CS Medica, a Danish medico cannabis company developing, manufacturing, and commercialising over-the-counter (OTC) medical device products containing cannabinoids, is to launch an IPO, with shares to be listed on the Spotlight Stock Market in Q3 2021. The company, founded in 2011, has a current focus on cannabidiol for the treatment of psoriasis and arthritis. It has…
Home Healthcare Markets International Business Denmark: CS Medica unveils plans for Q3 IPO and listing on Spotlight...